Ceesay Abraham Insider Trades & Stock Holdings

Chief Executive Officer · Rapport Therapeutics, Inc. · Latest filing Oct 7, 2026

Ceesay Abraham, Chief Executive Officer at Rapport Therapeutics, Inc. has 3 Form 4 trades on file since Sep 23, 2026. Open-market activity: 0 purchases ($0) and 3 sales ($229.84K), net -$229.84K. Latest filing: disposed of 1.15K shares of $RAPP on Oct 7, 2026 at $30.66.

Trades on file

3

Open-market bought

$0

Open-market sold

$229.84K

Net open-market

-$229.84K

Latest filing

Oct 7, 2026

All insider trades by Ceesay Abraham

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 7, 2026	$RAPP	Sell (Open-market sale) 10b5-1	1.15K	$30.66	$35.17K			-8.2%			Chief Executive Officer		—
Oct 6, 2026	$RAPP	Sell (Open-market sale) 10b5-1	3.38K	$32.03	$108.11K			-6.9%			Chief Executive Officer		—
Sep 23, 2026	$RAPP	Sell (Open-market sale) 10b5-1	2.21K	$39.17	$86.57K			-1.6%			Chief Executive Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Ceesay Abraham traded

• $RAPP

Frequently asked questions

Has Ceesay Abraham been buying or selling stock?

Ceesay Abraham has 0 open-market purchases and 3 open-market sales on file, net -$229.84K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Ceesay Abraham's latest insider trade?

disposed of 1.15K shares of $RAPP on Oct 7, 2026 at $30.66.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.